| Secondary |
| Osteoporosis |
17.5% |
| Lupus Nephritis |
12.3% |
| Product Used For Unknown Indication |
10.5% |
| Hypertension |
9.6% |
| Hypocalcaemia |
7.0% |
| Prophylaxis |
4.4% |
| Arthralgia |
3.5% |
| Dementia Alzheimer's Type |
3.5% |
| Gastritis |
3.5% |
| Hyperlipidaemia |
3.5% |
| Hypotension |
3.5% |
| Osteoarthritis |
3.5% |
| Cystitis |
2.6% |
| Depression |
2.6% |
| Pain |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Bronchitis Chronic |
1.8% |
| Hypersensitivity |
1.8% |
| Hypoparathyroidism |
1.8% |
| Lower Respiratory Tract Infection |
1.8% |
|
| Abortion Missed |
11.1% |
| Hypercalcaemia |
11.1% |
| Hallucination |
8.3% |
| Liver Disorder |
8.3% |
| Pyelonephritis |
8.3% |
| Pyrexia |
8.3% |
| Sepsis |
5.6% |
| Thrombocytopenia |
5.6% |
| Arrhythmia |
2.8% |
| Blood Potassium Increased |
2.8% |
| Chest Discomfort |
2.8% |
| Drug Eruption |
2.8% |
| Hypocalcaemia |
2.8% |
| Hypokalaemia |
2.8% |
| Intracranial Pressure Increased |
2.8% |
| Melaena |
2.8% |
| Pneumonia |
2.8% |
| Pulmonary Embolism |
2.8% |
| Toxic Epidermal Necrolysis |
2.8% |
| Urinary Tract Infection |
2.8% |
|
| Concomitant |
| Rheumatoid Arthritis |
30.7% |
| Osteoporosis |
15.6% |
| Product Used For Unknown Indication |
11.7% |
| Drug Use For Unknown Indication |
6.8% |
| Hypertension |
6.6% |
| Prophylaxis |
5.2% |
| Pain |
2.8% |
| Gastric Ulcer |
2.3% |
| Prophylaxis Against Transplant Rejection |
2.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.0% |
| Infection |
1.7% |
| Diabetes Mellitus |
1.5% |
| Gastritis |
1.5% |
| Constipation |
1.4% |
| Insomnia |
1.4% |
| Reflux Oesophagitis |
1.3% |
| Renal Failure Chronic |
1.3% |
| Hyperlipidaemia |
1.2% |
| Osteoporosis Prophylaxis |
1.2% |
| Pulmonary Hypertension |
1.2% |
|
| Hepatorenal Syndrome |
8.0% |
| Urinary Tract Infection |
8.0% |
| Pneumocystis Jiroveci Pneumonia |
7.1% |
| Hepatic Function Abnormal |
6.3% |
| Pleural Effusion |
6.3% |
| Vomiting |
6.3% |
| Loss Of Consciousness |
5.4% |
| Parkinsonism |
5.4% |
| Purpura |
5.4% |
| Death |
4.5% |
| Interstitial Lung Disease |
4.5% |
| Pyrexia |
4.5% |
| Cardiac Failure |
3.6% |
| Gingival Hyperplasia |
3.6% |
| Lymphocele |
3.6% |
| Pneumonia |
3.6% |
| Retinal Haemorrhage |
3.6% |
| Spondylitis |
3.6% |
| Ventricular Extrasystoles |
3.6% |
| Vesical Fistula |
3.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
46.2% |
| Endometriosis |
23.1% |
| Hypoparathyroidism |
23.1% |
| Grand Mal Convulsion |
7.7% |
|
| Drug Interaction |
75.0% |
| Drug Level Decreased |
25.0% |
|
